Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial.
暂无分享，去创建一个
A. Sette | R. Coler | S. Reed | A. Diacon | A. Fiore-Gartland | M. Tameris | M. Hatherill | T. Scriba | L. Bekker | G. Walzl | C. L. Lindestam Arlehamn | T. Day | A. Luabeya | A. Penn-Nicholson | N. Bilek | N. du Plessis | A. Loxton | T. Reid | Aude Frevol | Julie A Vergara | Tom Rolf | Z. Sagawa | Simbarashe Mabwe | Asma Toefy | H. Geldenhuys | J. Shenje | Jill A Ashman | Hendrik Geldenhuys | Nelita du Plessis